Talk:Nuclear–cytoplasmic ratio

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Medicine: Pathology Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Pathology task force.

Requested move 19 January 2024

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: Moved to Nuclear–cytoplasmic ratio. (closed by non-admin page mover) Adumbrativus (talk) 09:16, 7 February 2024 (UTC)[reply]

NC ratio → Nuclear-cytoplasmic ratio – Alternative, unrestricted title. JohnCWiesenthal (talk) 05:19, 16 January 2024 (UTC) This is a contested technical request (permalink). – robertsky (talk) 15:12, 19 January 2024 (UTC) — Relisting. – robertsky (talk) 07:15, 31 January 2024 (UTC)[reply]

- @JohnCWiesenthal: En dash or slash should be used instead of hyphen per MOS:ENBETWEEN. The existing redirect can be retargeted without special permissions. PleaseStand (talk) 20:13, 16 January 2024 (UTC)[reply]
  @PleaseStand: I'd agree that ENBETWEEN would call for a dash in "nucleus–cytoplasm ratio", since that means "nucleus-to-cytoplasm ratio". But this would imply "nuclear-to-cytoplasmic ratio". SilverLocust 💬 23:08, 16 January 2024 (UTC)[reply]
  @SilverLocust ENBETWEEN does say though that "The components may be nouns, adjectives, verbs, or any other independent part of speech." And I'm not sure that "nuclear-to-cytoplasmic [volume] ratio" is any less valid of a construction than, say, "observed-to-expected [events] ratio" or "wide-to-narrow [bar width] ratio". PleaseStand (talk) 02:42, 17 January 2024 (UTC)[reply]
  Fair enough. SilverLocust 💬 02:55, 17 January 2024 (UTC)[reply]

Note: WikiProject Molecular Biology has been notified of this discussion. – robertsky (talk) 07:15, 31 January 2024 (UTC)[reply]

Note: WikiProject Medicine has been notified of this discussion. – robertsky (talk) 07:15, 31 January 2024 (UTC)[reply]

Support as it appears to be by far the common name. And yes, style it with en dash. Dicklyon (talk) 23:33, 31 January 2024 (UTC)[reply]
Support with EN dash, as the WP:NATURAL disambiguation of the move would be an improvement regardless of what experts expect the common name to be. Similarly, I would also support a move to Nucleus-to-cytoplasm ratio. ― Synpath 03:30, 1 February 2024 (UTC)[reply]
support per Synpath--Ozzie10aaaa (talk) 13:40, 2 February 2024 (UTC)[reply]

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.